Role of fibrinolytic markers in acute stroke

Singapore Medical Journal

Volumn 50, Issue 6, 2009, Pages 604-609

  Abdullah, Wan Zaidah ^a   Idris, S Z ^a   Bashkar, S ^a   Hassan, R ^a  

^a SCHOOL OF MEDICAL SCIENCES   (Malaysia)

Author keywords

Acute stroke; Plasminogen; Plasminogen activator inhibitor 1 (PAI 1); Tissue plasminogen activator (t PA)

Indexed keywords

FIBRINOLYTIC AGENT; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE DISEASE; ADULT; AGED; ANALYSIS OF COVARIANCE; ARTICLE; BLOOD SAMPLING; CEREBROVASCULAR DISEASE; COLORIMETRY; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; FIBRINOLYSIS; FOLLOW UP; HEMOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR; STATISTICAL SIGNIFICANCE; STROKE; SURVIVAL; VASCULAR ENDOTHELIUM;

AGED; COLORIMETRY; FEMALE; FIBRINOLYSIS; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; STROKE; TISSUE PLASMINOGEN ACTIVATOR;

EID: 67849103288     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Kemball-Cook G, Tuddenham EGD, McVey JH. Normal haemostasis. In: Hoffbrand AV, Catovsky D, Tuddenham EGD, eds. Postgraduate Haematology. 5th ed. Oxford: Wiley-Blackwell, 2005: 783-807.
2. Carter AM, Catto AJ, Grant PJ. Determinants of tPA antigens and associations with coronary artery disease and acute cerebrovascular disease. Thromb Haemost 1998; 80:632-636
3. Ridker PM, Hennekens CH, Stampfer MJ, Manson JE, Vaughan DE. Prospective study of endogenous tissue plasminogen activator and risk of stroke. Lancet 1994; 343:940-943
4. Lindgren A, Lindoff C, Norrving B, Astedt B, Johansson BB. Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients. Stroke 1996; 27:1066-1071 (Pubitemid 26177608)
5. Hoekstra T, Geleijnse JM, Kluft C, et al. 4G/4G genotype of PAI-1 gene is associated with reduced risk of stroke in elderly. Stroke 2003; 34:2822-2828 (Pubitemid 37517749)
6. Roest M, Banga JD. Editorial comment - genetic make-up for increased PAI-1 expression protects against stroke. Stroke 2003; 34:2828-2829
7. Jaya F, Win MN, Abdullah MR, Abdullah MR, Abdullah JM. Stroke patterns in Northeast Malaysia: a hospital-based prospective study. Neuroepidemiology 2002; 21:28-35. (Pubitemid 34042859)
8. Macko RF, Kittner SJ, Epstein A, et al. Elevated tissue plasminogen activator antigen and stroke risk: The Stroke Prevention in Young Women Study. Stroke 1999; 30:7-11. (Pubitemid 29029433)
9. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988; 19:604-607 (Pubitemid 18126965)
10. Rånby M, Bergsdorf N, Nilsson T, et al. Age dependence of tissue plasminogen activator concentrations in plasma, as studied by an improved enzyme-linked immunosorbent assay. Clin Chem 1986; 32:2160-2165 (Pubitemid 17031627)
11. Sundell IB, Nilsson TK, Rånby M, Hallmans G, Hellsten G. Fibrinolytic variables are related to age, sex, blood pressure and body build measurements: a cross sectional study in Norsjö, Sweden. J Clin Epidemiol 1989; 42:719-723 (Pubitemid 19213116)
12. Declerck PJ, Alessi MC, Verstreken M, et al. Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-link immunosorbent assay. Blood 1988; 71:220-225 (Pubitemid 18050415)
13. Laffan MA, Manning RA. Investigation of thrombotic tendency: In: Lewis SM, Bain BJ, Bates I, Dacie JV, eds. Dacie and Lewis Practical Haematology. 10th ed. Philadelphia: Churchill Livingstone, 2006: 454-455
14. Margaglione M, Di Minno G, Grandone E, et al. Abnormally high circulation levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in patients with a history of ischemic stroke. Arterioscler Thromb 1994; 14:1741-1745 (Pubitemid 124004592)
15. Johansson L, Jansson JH, Boman K, et al. Tissue plasminogen activator, plasminogen activator inhibitor-1, and tissue plasminogen activator/ plasminogen activator inhibitor-1 complex as risk factors for the development of a first stroke. Stroke 2000; 31:26-32. (Pubitemid 30035748)
16. Strickland S. Tissue plasminogen activator in nervous system function and dysfunction. Thromb Haemost 2001; 86:138-143 (Pubitemid 32663946)
17. Eitzman DT, Westrick RJ, Xu Z, Tyson J, Ginsburg D. Plasminogen activator inhibitor-1 deficiency protects against atherosclerosis progression in the mouse carotid artery. Blood 2000; 96:4212-4215
18. Luttun A, Lupu F, Storkebaum E, et al. Lack of plasminogen activator inhibitor-1 promotes growth and abnormal matrix remodeling of advanced atherosclerotic plaques in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2002; 22:499-505. (Pubitemid 34218761)
19. de Waard V, Arkenbout EK, Carmeliet P, Lindner V, Pannekoek H. Plasminogen activator inhibitor 1 and vitronectin protect against stenosis in a murine carotid artery ligation model. Arterioscler Thromb Vasc Biol 2002; 22:1978-1983 (Pubitemid 36025202)
20. Saidi S, Slamia LB, Mahjoub T, Ammou SB, Almawi WY. Association of PAI-1 4G/5G and -844G/A gene polymorphism and changes in PAI-1/tPA levels in stroke: a case-control study. J Stroke Cerebrovasc Dis 2007; 16:153-159 (Pubitemid 47048920)
21. Kain K, Catto AJ, Carter AM, et al. Decreased fibrinolytic potential in South Asian women with ischaemic cerebrovascular disease. Br J Haematol 2001; 114:155-161 (Pubitemid 32702649)
22. Maria C, Edoardo P, Gianni C, et al. Impact of mild hypertriglyceridemia on fibrinolysis, Lp(a), and platelet activation indexes in mildly hypercholesterolemic patients. Int J Angiol 1997; 6:71-74
23. Lu J. [Observation of plasma levels of antithrombin-III and plasminogen in acute cerebrovascular disease]. Zhonghua Shen Jing Jing Shen Ke Za Zhi 1989; 22:205-7, 252-253 Chinese.